ctrl K

Price Alert

Kazia Therapeutics Limite... (KZIA)

NASDAQ: KZIA · Real-Time Price · USD

7.23

0.23 (3.29%)

At close: Aug 21, 2025, 11:21 AM

Kazia Therapeutics Income Statement

Financials in AUD. Fiscal year is July - June.

Fiscal Year	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021
Period Ending	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020
Revenue	2.48M	5.00	555.00	n/a	-2.9M	10K	15.18M	1.17K
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	2.88M	n/a
Gross Profit	2.48M	5.00	555.00	n/a	-2.9M	10K	12.3M	1.17K
Operating Income	-19.58M	-8.88M	-10.51M	-13.64M	-11.94M	-13.45M	55.65K	-6.43M
Interest Income	n/a	6.45K	22.42K	139.00	105.00	1.99K	11.42K	30.82K
Pretax Income	-18.09M	-8.96M	-7.01M	-13.72M	-11.86M	-13.52M	-2.39M	-6.51M
Net Income	-17.95M	-8.82M	-6.88M	-13.59M	-11.81M	-13.2M	-2.06M	-6.36M
Selling & General & Admin	9.01M	4.56M	4.31M	4.28M	2.76M	2.48M	3.45M	3.58M
Research & Development	13.05M	4.33M	6.2M	9.36M	9.18M	10.99M	11.68M	2.86M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	22.06M	8.88M	7.04M	13.72M	11.86M	13.53M	17.59M	6.54M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	127.04K	n/a	n/a	n/a
Cost & Expenses	22.06M	8.88M	7.04M	13.72M	11.86M	13.53M	17.59M	6.54M
Income Tax Expense	135.45K	135.55K	135.55K	135.55K	52.11K	315.97K	335.25K	149.1K
Shares Outstanding (Basic)	575.2K	479.6K	456K	291.4K	266K	264K	264K	214.8K
Shares Outstanding (Diluted)	575.2K	479.6K	456K	291.4K	266K	264K	264K	214.8K
EPS (Basic)	-31.2	-18.4	-15.1	-46.65	-44.4	-50	-7.8	-29.6
EPS (Diluted)	-31.2	-18.4	-15.1	-46.65	-44.4	-50	-7.8	-29.6
EBITDA	-18.64M	-7.95M	-9.58M	-12.7M	-11M	-12.51M	778.79K	-5.89M
EBIT	-19.58M	-8.88M	-10.51M	-13.64M	-11.94M	-13.45M	55.65K	-6.43M
Depreciation & Amortization	934.29K	934.71K	934.72K	934.74K	934.71K	934.71K	723.14K	542.17K